858 TILKine-2: a novel best-in-class tumor infiltrating lymphocyte (TIL) targeting engineered IL-2 with superior pre-clinical efficacy and safety for immunotherapy of cancer

• Sreerupa Challa,
• Jonathan Carnino,
• Andrea Umana,
• Yuesheng Li,
• Lingyun Rui,
• Yao-Te Hsieh

Affiliations

Sreerupa Challa

Cugene, Waltham, MA, USA

Jonathan Carnino

Cugene, Waltham, MA, USA

Andrea Umana

Cugene, Waltham, MA, USA

Yuesheng Li

Cugene, Waltham, MA, USA

Lingyun Rui

Cugene, Waltham, MA, USA

Yao-Te Hsieh

Cugene, Waltham, MA, USA